Winship Cancer Institute study may provide a ray of hope for some lung cancer patients:

A new treatment standard may be in the making for some patients with lung cancer, a study by the Winship Cancer Institute at Emory University suggests. More patients with non-small cell lung cancer (NSCLC) that is locally advanced lived five years or longer when they had received radiation and chemotherapy at the same time (concurrently) than those who had received the treatment in sequence, the study found. Traditional treatment protocols typically call for chemotherapy to be administered first for patients with locally advanced NSCLC. Patients then undergo radiation therapy.

Click here to read full press release from Winship Cancer Institute.

Among the research institutions NCI funds across the United States, it currently designates 66 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.